DERIVATIVE SEGMENT – 7
DERIVATIVE SEGMENT – 7 FUTURES MARKET TERMINOLOGIES SPOT PRICE – The price at which an asset trades in the cash market. this is the underlying value of nifty on July
“We the retailers of market solemnly……
A journey with our mind… “We the retailers of market solemnly…… The most confused people in the market are retail traders. Because their decision depends on other’s plan execution before
TCS Q1 result- insight and impact on market
Tata Consultancy Services Q1 Results profit rise by 8.72% YOY, stock was up by 7.2% Tata Consultancy Services (TCS) reported their Q1 results for FY2024 on July 11, 2024. Here
PROBABILITES OF DALAL STREET ON 12th JULY 2024
PROBABILITES OF DALAL STREET ON 12th JULY 2024 Dear market participants, today also nifty closed in red but again it took support at 24200 as we discussed this week contracts
Adani Group’s Vizhinjam Port Welcomes First Mothership, Elevating India to Global Status
Adani Group’s Vizhinjam Port Welcomes First Mothership, Elevating India to Global Status Thiruvananthapuram: Adani Group’s Vizhinjam Port, India’s first trans-shipment port near Kovalam Beach in Kerala, received its first mothership,
Jefferies Predicts Jio’s $112 Billion Valuation
Jefferies Predicts Jio’s $112 Billion Valuation and Weighs IPO vs. Spin-Off for RIL Jefferies, a foreign brokerage, recently released a note discussing the potential value of Reliance Industries Ltd (RIL)’s
Vedanta plans to raise Rs 8,000 crore through a QIP
Vedanta plans to raise Rs 8,000 crore through a QIP, appoints bankers for the issue. Vedanta, a major company, announced that it is raising ₹1,000 crore by issuing 1 lakh
PROBABILITES OF DALAL STREET ON 11th JULY 2024
PROBABILITES OF DALAL STREET ON 11th JULY 2024 Dear market participants, today nifty closed in red. As per our yesterday view, every dip allows bull entry today it happened. For
DERIVATIVE SEGMENT – 6
DERIVATIVE SEGMENT – 6 INTRODUCTION TO FORWARDS A forward contract is an agreement made directly between two parties to buy or sell an asset on a specific date in the
Glenmark Pharma
Add Your Heading Text Here The sale of a 7.84% stake in Glenmark Life Sciences by Glenmark Pharma, as approved by its board, involves several key details and processes. Here’s